Vaxart Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -714.0% | -416.7% | -971.6% | -187.9% | -85.2% | -48.4% | -46.0% | -40.1% | 3.6% | 29.4% | -5.2% | 10.2% | 14.0% | |
| 98.3% | 37.0% | 99.8% | 34.6% | 45.1% | 14.7% | 10.8% | 5.4% | 2.9% | 2.3% | 2.9% | 2.7% | 2.6% | |
| 182.9% | 114.5% | 188.7% | 39.9% | 50.2% | 15.5% | 11.8% | 5.3% | 2.8% | 1.6% | 3.8% | 4.7% | 2.7% | |
| -164.3% | -76.9% | -35.6% | -4.6% | 21.7% | -3.6% | 16.4% | -11.1% | 8.4% | -26.5% | -25.4% | 49.6% | -7.4% | |
| 13.4% | 3.2% | 6.0% | 5.8% | 0.2% | 0.3% | 0.6% | 0.3% | 0.2% | 0.0% | 1.1% | 0.1% | 0.2% | |
| 236.6% | 465.5% | -230.4% | -151.0% | -345.4% | 68.5% | 63.4% | 18.2% | -8.0% | 1.9% | -1.7% | -10.0% | -3.0% | |
| -0.4% | -10.1% | -8.3% | -0.3% | -0.2% | -1.2% | – | – | – | – | – | – | – | |
| -0.4% | -2.0% | 834.3% | 597.4% | -0.2% | 0.9% | -0.8% | 0.3% | 0.0% | 4.1% | -0.9% | 0.4% | 1.7% | |
| -477.8% | 46.7% | -367.7% | 258.6% | -430.8% | 21.0% | 16.6% | -21.6% | -4.5% | 35.4% | -7.8% | 0.7% | 12.7% | |
| -727.4% | -413.5% | -977.6% | -193.7% | -85.3% | -48.7% | -46.6% | -39.9% | 3.4% | 29.4% | -6.4% | 10.1% | 13.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.